Tori Spelling And Daughter Stella Open Up About Struggles With Eczema
Actress and author Tori Spelling and her daughter Stella McDermott have recently opened up about their struggles with eczema. Eczema is a group of inflammatory skin conditions that affects a significant portion of the population worldwide. Despite its prevalence, there is still a lack of awareness and understanding surrounding the condition.
Spelling shared that she was not fully aware of eczema until she began experiencing it herself as an adult. She attributed the onset of her eczema to a particularly stressful period in her life. The symptoms of itching, pain, and inflammation were challenging to deal with and impacted her daily life. Similarly, McDermott has been dealing with eczema since childhood, experiencing bullying and discomfort throughout her school years.
The mother-daughter duo tried various treatments for their eczema, including steroid creams that often worsened their symptoms. It was a frustrating and exhausting process trying to find a solution that worked for them. However, they eventually found relief with Zoryve, a topical medication from Arcutis Biotherapeutics, Inc. that does not contain steroids. Zoryve contains roflumilast, which inhibits the activity of phosphodiesterase-4 and reduces inflammation.
Dr. Adam Friedman, a dermatologist, emphasized the importance of targeted therapy for specific skin conditions like eczema. He highlighted the advancements in treatment options over the past decade, providing more effective and tailored solutions for patients. Friedman also stressed the importance of consulting a healthcare professional before trying any new treatments, as individual responses can vary.
With their eczema under control, Spelling and McDermott are now able to focus on their respective projects and enjoy life without the burden of constant skin irritation. Spelling is active with her podcasts misSPELLING and 9021OMG, while McDermott is looking forward to her senior year milestones like prom and graduation.
Overall, their journey with eczema has been challenging, but finding the right treatment has made a significant difference in their quality of life. By sharing their experiences, Spelling and McDermott hope to raise awareness and reduce the stigma surrounding inflammatory skin conditions. Their partnership with Arcutis Biotherapeutics, Inc. for the “Free To Be Me” campaign aims to promote understanding and support for individuals dealing with eczema and other skin conditions.
